Introduction {#Sec1}
============

Hirschsprung's disease (HSCR) is a rare disease characterized by the absence of ganglion cells along a variable length in the gastrointestinal tract, which results in the contraction of the aganglionic gut segment and functional intestinal obstruction \[[@CR1]\]. HSCR is mainly caused by a failure in migration of enteric neural crest cells into the intestinal tract, or due to a failure in survival, proliferation, or differentiation of enteric neural crest cells once they reach the gut. It has a morbidity of 1/5,000 live births and is most prevalent among Asians \[[@CR2]\]. Moreover, males are affected about 3.5--7.8 times more than females \[[@CR3]\]. According to the extent of aganglionosis, HSCR patients can be classified as short-segment HSCR (S-HSCR, 80 % of cases), when the aganglionic segment does not extend beyond the upper sigmoid, and long segment HSCR (L-HSCR, 20 % of cases), when aganglionosis extends proximal to the sigmoid \[[@CR4]\]. Clinical manifestations of HSCR include constipation, distension of the proximal colon, and concomitant complications \[[@CR5]\].

*CYP2B6*, which is located on chromosome 19, codes metabolic enzyme of the Cytochrome P450 family \[[@CR6], [@CR7]\]. *CYP2B6* acts as the phase I metabolic enzyme and plays a key role in the biotransformation of many xenobiotics \[[@CR8]\]. If the xenobiotics as precarcinogens transform to their biologically active forms, they then may irreversibly react with DNA to cause mutations, chromosomal aberrations, and cancer, including congenital disorder such as HSCR \[[@CR9]\]. The human gene coding for *CYP2B6* is highly polymorphic while the hepatic content and activity of the enzyme itself are subject to wide variation \[[@CR10]\]. It was reported that *CYP2B6* polymorphism was associated with some diseases, such as leukemia \[[@CR11]\]. In this study, we proposed to understand whether genetic variants in *CYP2B6* were associated with HSCR.

Methods {#Sec2}
=======

Patients and Blood Samples {#Sec3}
--------------------------

The Institutional Ethics Committee approval for the project was obtained before the study started. Activities involving subjects were performed in accordance with the declaration of Helsinki. A total of 262 blood samples were recruited from HSCR patient acquired surgical treatment in Nanjing Children's Hospital affiliated to Nanjing Medical University and Xuzhou Children's Hospital Affiliated to Xuzhou medical college from July 2010 to 2013. Pathological detection was performed after surgery in order to verify that the ganglion cells could not be detected in the aganglionic segments. A total of 290 samples in control group were blood obtained from patients undergoing surgical treatment for intussusception or incarcerated and strangulated inguinal hernia, and all samples were proved without HSCR or other congenital malformation. Patients and controls were matched by ethnicity, mean age, and gender. Both the HSCR and control group samples were collected after obtaining informed consent from their guardians for the collection of the blood. The blood tissues were immediately frozen and stored at −20 °C.

Genomic DNA Extraction and Polymorphism Genotyping {#Sec4}
--------------------------------------------------

Blood samples were obtained from each individual and used for DNA extraction. Genomic DNA was extracted by using a DNA extraction kit (Tiangen Biotech, Beijing, China) according to the manufacturer's instructions. SNPs of the *CYP2B6* gene (rs707265, rs1042389, and rs2054675) were genotyped by the TaqMan Probe method on the ABI 7900 Real-time PCR system (Applied Biosystems, Foster City, CA, USA). SDS 2.4 software was used for allelic discrimination. For quality control, four negative controls were included in each plate, and 5 % of the samples were randomly selected for repeated genotyping to verify the results; all of the results were 100 % consistent. These SNPs (rs707265, rs1042389, and rs2054675) had been reported to be associated with other diseases or located in potential function areas, and the minor allele frequencies (MAF) value is greater than 0.05 in Chinese population.

Statistical Analysis {#Sec5}
--------------------

Genotype frequencies of all polymorphisms were tested for Hardy--Weinberg equilibrium. Statistical analysis was performed using Stata software (version 7.0, Stata Corp LP, College Station, TX, USA). Demographic characteristics of patients and controls were described as frequencies and percentages. Statistical significance of frequency differences between patients and control groups was evaluated using the Chi-squared test as well as the disease classification and genotype. Statistical odds ratios (OR) for risk prediction were derived by logistic regression analysis, and estimation was made with 95 % confidence intervals (95 % CI). Bonferroni adjustment was used to control the error rate due to multiple testing. As the result, a *p* value lower than 0.0167 (0.05/3) was considered statistically significant.

Results {#Sec6}
=======

The genotype distribution among controls and patients was in Hardy--Weinberg equilibrium. Distributions of the alleles and genotypes for SNPs were presented in Table [1](#Tab1){ref-type="table"}. Significant associations were observed between the allele frequencies of rs707265 and the risk of HSCR (*p* \< 0.001) (Table [2](#Tab2){ref-type="table"}). The frequency of the homozygous AA genotype of rs707265 was lower in control group (Table [1](#Tab1){ref-type="table"}). We observed higher frequency of heterozygous GA genotype of rs707265 in case group (*p* = 0.001, adjusted OR 2.09, 95 % CI 1.36----3.19 in GA genotype group) (Table [1](#Tab1){ref-type="table"}), and the difference between combined variant genotypes GA\\AA and GG was also significant (*p* \< 0.001, adjusted OR 2.98, 95 % CI 2.00--4.45).Table 1Associations between CYP2B6 polymorphisms and risk of HSCRGenotypesCases (*n* = 262)^a^Controls (*n* = 290)^a^*p* ^b^Adjusted OR (95 % CI)^c^*n*%*n*%rs707265 (G\>A) GG4517.1711138.271.00 GA11744.6613847.590.0012.09 (1.36--3.19) AA10038.174114.14\<0.0016.03 (3.65--9.98) GA/AA21782.8317961.73\<0.0012.98 (2.00--4.45)rs1042389 (T\>C) TT14354.5815754.141.00 TC9636.6410235.170.8561.03 (0.72--1.48) CC238.783110.690.5040.82 (0.46--1.47) TC/CC11945.4213345.860.9871.00 (0.71--1.40)rs2054675 (T\>C) TT17767.5618864.831.00 TC7629.019432.410.4150.86 (0.60--1.24) CC93.4382.760.7051.21 (0.46--3.20) TC/CC8532.4410235.170.5310.89 (0.63--1.27)^a^The observed genotype frequency among the control subjects was in agreement with the Hardy--Weinberg equilibrium^b^Chi-square test for genotype distribution^c^Obtained from logistic regression model with adjustment for age and sexTable 2Differences of allele frequencies of SNPs rs707265, rs1042389, and rs2054675 between cases and controlsCaseControl*p* ^a^*n* = 262%*n* = 290%rs707265 (G\>A) G20739.5036062.07\<0.001 A31760.5022037.93rs1042389 (T\>C) T38272.9041671.720.663 C14227.1016428.28rs2054675 (T\>C) T43082.0647081.030.661 C9417.9411018.97^a^ *p* \< 0.05 for Student's *t* test for selected characteristics distributions between the control and case groups

There were no significant differences between allele frequencies of rs1042389 T and C in cases and controls (*p* = 0.663) (Table [2](#Tab2){ref-type="table"}). Genotype frequencies were of no significant difference between cases and controls (Table [1](#Tab1){ref-type="table"}). As for rs2054675 (T\>C), the genotype frequencies were TT 67.56 %, TC 29.01 %, CC 3.43 % in cases and TT 64.83 %, TC 32.41 %, CC 2.76 % in controls (Table [1](#Tab1){ref-type="table"}). The allele frequencies were T 82.06 %, C 17.94 % in cases and T 81.03 %, C 18.97 % in control subjects (Table [2](#Tab2){ref-type="table"}). We found no difference in the rs1042389 and rs2054675 genotype frequencies or allele frequencies between cases and controls.

For the relationship between disease classification and genotype, no significant associations were observed (Table [3](#Tab3){ref-type="table"}).Table 3The relationship between disease classification and genotypers707265 (G\>A)rs1042389 (T\>C)rs2054675 (T\>C)GGGAAA*p* ^b^TTTCCC*p* ^b^TTTCCC*p* ^b^L-HSCR^a^23635679521196397S-HSCR^a^2254440.8576444120.803813720.321Ultra-short HSCR^a^514100.88215950.27322610.680^a^Total colonic aganglionosis and total intestinal HSCR are classified in L-HSCR^b^Chi-square test for selected characteristics distributions between the L-HSCR/S-HSCR groups and L-HSCR/ultra-short HSCR groups

Discussion {#Sec7}
==========

A number of studies had implicated defects in neurons since the early 1900s, but it was not found that all postmortem samples of rectum from patients with congenital megacolon lacked enteric (intrinsic) neurons until the mid-1900s \[[@CR12]\]. It has been assumed that all cases of HSCR have a genetic basis, but mutations in genes associated with HSCR account for only about 50 % of familial cases of HSCR and 15 % of sporadic cases of HSCR \[[@CR2]\]. Experimental results have confirmed that vitamin A deficiency increases the penetrance and severity of aganglionosis in a mouse model of HSCR \[[@CR13]\]. Thus, environmental factors could contribute to susceptibility to HSCR \[[@CR14]\].

The metabolism of environmental factors mainly performed by metabolic enzymes; however, *CYP2B6* is an important metabolic enzyme. *CYP2B6* protein is mainly expressed in the liver, which contributes 2--5 % of the total liver *CYP* content and exhibits about 300-fold variability of expression \[[@CR15]\], but can be also expressed in the kidneys, intestines, skin, brain, and lungs \[[@CR16]\]. *CYP2B6* has been found to metabolize partially or primarily metabolism of many important drugs, environmental contaminants, and mutagens \[[@CR9]\]. In vitro studies have shown that overexpression of *CYP* (*CYP2C9*) elicits angiogenesis via activation of the epidermal growth factor receptor (*EGFR*) \[[@CR17]\], which plays an important role in migration. The overexpression of *CYP* epoxygenase enhanced tumor metastasis of human breast carcinoma cells to the lungs of athymic BALB/C and also notably enhanced the migration, invasion in a variety of cancer cell lines in vitro \[[@CR17], [@CR18]\]. Moreover, enteric neural crest cells migration disorder could be important in the pathogenesis of HSCR. Thus, we hypothesize that CYP2B6 affected migration of enteric neural crest cells and modified the risk of HSCR.

Genetic variations such as single nucleotide polymorphisms (SNPs) were thought to be important in determining the biological basis of complex genetic conditions. There were several polymorphisms in *RET*, *NRG1*, *SEMA3A* genes, which have been known to be risk factors for HSCR \[[@CR3], [@CR19]\]. Our study is the first to suggest associations between *CYP2B6* polymorphisms and HSCR risk. In this paper, a total of 552 individuals were analyzed. For the SNP (rs1042389 and rs2054675), we did not detect any significant difference in genotype distribution or allele frequency between cases and controls. The results indicated that rs1042389 and rs2054675 in *CYP2B6* had no association with susceptibility or risk to HSCR in the Chinese Han population. We found that the *CYP2B6* rs707265 AA genotypes were associated with a high risk on HSCR compared with the GG genotype. Compared with G allele, the A allele (allele frequency 60.50 % in cases, 30.40 % from dbSNP) may have a high susceptibility to HSCR (*p* \< 0.001). Because of this, we suspect that rs707265 (G\>A) polymorphism may result in different capabilities to dispose of exogenous contaminants and impact on the expression and function of *CYP2B6* proteins, which influencing the risk of HSCR.

In conclusion, we found *CYP2B6* rs706252 (G\>A) was associated with HSCR in Chinese Han population. However, further studies are needed to better understand the potential mechanisms.
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